Respiratory Outbreak Mitigation With Point-of-Care Testing in Long-Term Care
JAMA Internal Medicine 10.1001/jamainternmed.2026.2644July 06, 2026 at 11:00 AM EDT
Does point-of-care respiratory multiplex polymerase chain reaction (POC-RMPCR) testing in nursing homes (NHs) lead to smaller outbreak size or better resident outcomes due to SARS-CoV-2, influenza, and respiratory syncytial virus infection?In this cluster randomized trial of 20 NHs, use of an on-site POC-RMPCR instrument did not decrease outbreak number or size. POC-RMPCR enabled increased testing, improved case detection, and shorter time to initiation of antiviral therapy from symptom onset (influenza only).The trial results suggest that seasonal adoption of POC-RMPCR in NHs would avoid an estimated 4 hospital transfers per 100 beds, equivalent to 64 000 across the US each respiratory season.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.